HDAC9 and acute myeloid leukemia: Given that HDAC inhibitors were used to model drug resistance of AML, we examined acetylation profile of KG1a cells with histone mark H3K9, a post-translation modification associated with active transcription, to ask whether HDACi or acetate treatment transmits epigenetic modulation.